Professor ZHANG Shengsheng's idea of using ancient classic prescriptions to treat chronic atrophic gastritis and precancerous lesions of gastric cancer based on the "Tiaotai Xiaozheng"
-
摘要: 慢性萎缩性胃炎(chronic atrophic gastritis,CAG)及胃癌前病变(precancerous lesions of gastric cancer,PLGC)是消化系统的常见病及疑难病,存在一定的发展为胃癌的风险。中医药治疗CAG及PLGC显示出了较好的前景。张声生教授从事CAG及PLGC诊疗多年,经验丰富,对本病的诊治有独到的见解,将CAG及PLGC的病机总结为“虚、浊、滞、瘀、毒、癥”,总的治法为“调态消癥”,善用古代经典名方“调虚态、调浊态、调滞态、调瘀态、调毒态、消癥积”进行治疗,具有重要的临床价值,值得学习和借鉴。Abstract: Chronic atrophic gastritis(CAG) and precancerous lesions of gastric cancer(PLGC) are common and difficult diseases of the digestive system, and there is a certain risk of developing gastric cancer. Traditional Chinese Medicine shows good prospects for treating CAG and PLGC. Professor ZHANG Shengsheng has been engaged in the diagnosis and treatment of CAG and PLGC for many years. He has rich experience and has unique insights into the diagnosis and treatment of this disease. He summarizes the pathogenesis of CAG and PLGC as "deficiency, turbidity, stagnation, blood stasis, toxins, and Zheng", and the general treatment method is "Tiaotai Xiaozheng", and makes good use of ancient classic prescriptions for the treatment of "regulating deficiency, regulating turbidity, regulating stagnation, regulating blood stasis, regulating toxins, and eliminating Zheng", which has important clinical value and is worthy of learning and reference by clinical workers.
-
[1] Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
[2] 张声生, 李乾构, 唐旭东, 等. 慢性萎缩性胃炎中医诊疗共识意见(2009, 深圳)[J]. 中国中西医结合消化杂志, 2010, 18(5): 345-349. doi: 10.3969/j.issn.1671-038X.2010.03.024
[3] 房静远, 杜奕奇, 刘文忠, 等. 中国慢性胃炎诊治指南(2022年, 上海)[J]. 胃肠病学, 2023, 28(3): 149-180. https://www.cnki.com.cn/Article/CJFDTOTAL-WIEC202303004.htm
[4] 李丹艳, 赵鲁卿, 丁宁, 等. 张声生"调态消癥"辨治慢性萎缩性胃炎及胃癌前病变创新思路构建及运用[J]. 中华中医药杂志, 2024, 39(1): 229-234. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202401036.htm
[5] Chung CP, Hsia SM, Lee MY, et al. Gastroprotective activities of adlay(Coix lachryma-jobi L. var. ma-yuen Stapf) on the growth of the stomach cancer AGS cell line and indomethacin-induced gastric ulcers[J]. J Agric Food Chem, 2011, 59(11): 6025-6033. doi: 10.1021/jf2009556
[6] 王伟平, 吴寿海. 小建中汤治疗脾胃虚寒型慢性萎缩性胃炎的效果分析[J]. 当代医药论丛, 2019, 17(13): 199-200. https://www.cnki.com.cn/Article/CJFDTOTAL-QYWA201913149.htm
[7] 刘松华, 莫湘, 文黛薇, 等. NBI联合放大内镜对早期胃癌及癌前病变的观察研究[J]. 中国医药科学, 2016, 6(8): 23-26. https://www.cnki.com.cn/Article/CJFDTOTAL-GYKX201608008.htm
[8] 袁海锋, 唐少波, 奚锦要. 放大色素内镜下90例胃黏膜癌前病变形态学分析[J]. 中国内镜杂志, 2009, 15(3): 255-258. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGNJ200903012.htm
[9] 代二庆, 杨楠, 沈志红, 等. 64例慢性萎缩性胃炎中医证型与胃镜象、病理象相关性研究[J]. 辽宁中医杂志, 2016, 43(3): 458-461. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201603004.htm
[10] 徐佳燕, 郭金伟, 沈贤敏, 等. 络病理论指导下应用益气活血通络方治疗慢性萎缩性胃炎临床观察[J]. 广西中医药, 2020, 43(2): 5-7. https://www.cnki.com.cn/Article/CJFDTOTAL-GXZY202002005.htm
[11] 蔡甜甜, 林琳, 潘华峰, 等. 三七总皂苷激活JNK信号通路对胃癌前病变大鼠胃黏膜组织的保护作用[J]. 中华中医药杂志, 2019, 34(12): 5877-5880. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201912096.htm
[12] 王萍, 卞立群, 杨倩, 等. 慢性胃炎中医诊疗专家共识(2023)[J]. 中华中医药杂志, 2023, 38(12): 5904-5911. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202312106.htm
[13] 国家消化系疾病临床医学研究中心(上海), 国家消化道早癌防治中心联盟, 中华医学会消化病学分会幽门螺杆菌学组, 等. 中国胃黏膜癌前状态和癌前病变的处理策略专家共识(2020年)[J]. 中华消化内镜杂志, 2020, 37(11): 769-780.
计量
- 文章访问数: 126
- 施引文献: 0